ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Poláková et al. (52) detected a negative correlation between the levels of BCR-ABL transcript and miR-150, further substantiating previous findings by Agirre et al. (64) and Fallah et al. (54) suggested that the downregulation of miR-150 is a potential diagnostic marker of CML.